Morning Headaches and Unsteadiness in a Child: Medulloblastoma

Medically reviewed by Dr. Michael Kachur · Frankfurt, Germany·

A child is sick before breakfast and is fine by the school run. A week later it happens again. Then somebody notices he has started clipping door frames with his shoulder, and that his handwriting has got worse. The first answer is a stomach bug. The second is migraine, because his mother gets them. The third, weeks later, is a scan. Each answer was reasonable alone. What went wrong is that nobody held the vomiting, the balance and the handwriting as one complaint, and holding a case as one thing is what Healz is built to do.

Category
Health Insights
Date
Reading time
11 min
Share

This post follows the finding through: the pattern, the staging, the molecular group, and why treatment changes for a toddler.

Morning Headaches and Unsteadiness in a Child: Medulloblastoma

Why the vomiting comes first and the headache eases after

Medulloblastoma is the most common malignant brain tumour affecting children, and it most frequently arises at the level of the fourth ventricle within the posterior fossa, per a case-based review by Kline and colleagues in Neuro-Oncology Practice. The fourth ventricle is a narrow waypoint in the circulation of cerebrospinal fluid, and the NCI PDQ health professional summary states that most of the early symptomatology is related to blockage of that fluid, which produces hydrocephalus. The pressure, not the tumour mass, is what a family notices first. PDQ lists the presentation as relatively abrupt onset of headaches, especially in the morning on waking, nausea and vomiting, lethargy, ataxia including truncal unsteadiness, some degree of nystagmus, and papilloedema.

The part that misleads everyone is the relief. A 2013 review of childhood posterior fossa tumours by Aquilina in Advances in Clinical Neuroscience and Rehabilitation describes vomiting as usually an early morning phenomenon, possibly from irritation of the lower fourth ventricular floor at the area postrema by the tumour, and notes that the hyperventilation associated with vomiting often transiently improves the headache. So a child really does feel better after being sick, which is why the pattern gets filed under gastroenteritis. The same review puts ataxia down to vermal and cerebellar hemisphere involvement, brainstem dysfunction and chronic hydrocephalus, and says a head tilt may reflect tonsillar herniation or a fourth nerve palsy related to a diffuse brainstem tumour.

Ask Healz.

One chat instead of ten apps. 1M+ rare cases checked. The root cause, not the label. Private.

Infants report none of this. PDQ describes them presenting instead with nonspecific lethargy, developmental delay, feeding difficulties or an increase in head circumference, with a bulging anterior fontanelle and the sun-setting sign on examination. A baby who stops doing things he used to do is giving the signal an older child gives by complaining. Which headaches earn imaging at all is covered in our piece on the headache features that change the workup.

What the staging has to cover before anyone operates

This tumour spreads through the fluid it sits in. Kline and colleagues write that staging should include full spine MRI and spinal fluid cytology to assess for leptomeningeal dissemination, and PDQ states that imaging of the entire brain and spine is indicated, preferably before surgery, to avoid postoperative artefacts, especially blood. Operate first and the spinal images come back with blood that can read as deposits, and whether disease was already in the spine becomes unanswerable.

The spinal fluid goes the other way. After surgery, lumbar spinal fluid analysis is performed if deemed safe, and PDQ notes the analysis is conventionally done 14 to 21 days after surgery, because cells shed by the operation itself would otherwise be counted as metastatic disease. PDQ then counts a child as metastatic on neuroradiographic dissemination, positive spinal fluid cytology obtained after 14 days, or extraneural disease. Other tumours that start in the middle of the brain travel the same pathway, as our piece on a pineal region mass and its markers sets out.

The name of the tumour stopped being the whole diagnosis

A pathology report that says medulloblastoma and stops has not finished. In the 2021 fifth edition of the WHO classification of tumours of the central nervous system, summarised by Louis and colleagues in Neuro-Oncology, the molecularly defined types are medulloblastoma WNT-activated, medulloblastoma SHH-activated and TP53-wildtype, medulloblastoma SHH-activated and TP53-mutant, and medulloblastoma non-WNT/non-SHH. That summary states non-WNT/non-SHH medulloblastomas comprised group 3 and group 4 tumours, so the two groups people still name separately sit inside one type, with four SHH subgroups and eight non-WNT/non-SHH subgroups below. PDQ, which writes TP53-altered where the WHO summary writes TP53-mutant, puts it plainly: the WHO classification combines group 3 and group 4 medulloblastoma cases into a single entity. The old histological words survive as morphologic patterns of one inclusive tumour type, reported in layers alongside the molecular type.

The groups do not behave alike. PDQ puts WNT tumours at roughly 10% of cases, mostly in older children, with a very good outcome; SHH at about 25%, with TP53 status separating prognosis and TP53-altered tumours doing worse; and non-WNT/non-SHH at roughly 25% group 3 and 40% group 4.

How the risk group is actually assembled

Four things have to be in the room at once: age, resection, spread and the molecular work. PDQ describes average-risk disease in children older than 3 as a totally or near-totally resected tumour, meaning 1.5 square centimetres or less of residual disease, with no metastatic disease. High risk means metastatic disease and/or a subtotal resection leaving more than that, and diffuse anaplasia moves an otherwise average-risk child into the high-risk group. In younger children the age cut-offs vary between studies.

Group already changes what is offered, not only what is predicted. PDQ records that craniospinal radiation dose reduction to 18 Gy is currently being investigated in WNT medulloblastoma patients, and that one series which tried focal radiation alone, without craniospinal irradiation, in WNT disease showed an unacceptable incidence of neuraxial failure. For SHH-activated, TP53-altered tumours it says the optimal treatment has not been determined.

Treatment in a fixed order, and why radiation waits in a toddler

The order is consistent. PDQ describes total or near-total resection as optimal if it can be performed safely, then radiation, then chemotherapy, which it calls a standard component of treatment and which is usually given during and after radiation. Craniospinal radiation covers the whole brain and spine because the fluid pathway does, at 23.4 Gy to the neuraxis in average-risk disease and generally 36 Gy in high-risk disease, followed by a boost. PDQ notes that a boost to the tumour bed rather than the entire posterior fossa is equally effective, with possibly less toxicity.

For the youngest children the calculation changes, for a specific reason. PDQ states that debilitating effects on neurocognitive development, growth and endocrine function have been frequently observed, especially in younger children, and that efforts are made to omit or delay radiation therapy. For children 3 years and younger the described approach is surgery followed by adjuvant chemotherapy, with radiation generally avoided or deferred. Adding craniospinal irradiation to chemotherapy may help some children but brings anticipated neurodevelopmental decline, and there is no consensus on how much radiation to give or at what age to start it. Deferring radiation in a two-year-old is not caution. It is a choice between two kinds of harm.

One early complication deserves naming, because families are often not warned. PDQ describes cerebellar mutism syndrome, also called posterior fossa syndrome, appearing within one or two days after surgery, with loss of speech, suprabulbar palsies, ataxia, hypotonia and emotional lability. It occurred in nearly 25% of patients in two Children's Cancer Group studies, and Kline and colleagues put it at up to 30% after resection. PDQ adds that it was more common in group 3 and group 4 tumours, at 30% to 35%, than in SHH-activated tumours, at 7%, and that approximately 50% of affected patients have long-term, permanent sequelae. A child who comes out of theatre unable to speak is a known event, not a sign the operation failed.

What this diagnosis can say about the family

PDQ states that medulloblastoma can arise in the setting of hereditary cancer predisposition syndromes in approximately 5% of patients. Among those it names: Gorlin syndrome, also known as nevoid basal cell carcinoma syndrome; Li-Fraumeni syndrome, restricted to the SHH-activated subtype; and Turcot syndrome, from germline APC variants and exclusive to the WNT-activated subtype. The consequences are written in: PDQ says all patients with SHH-activated disease should be referred for genetic counselling, suggests germline APC testing in WNT-activated tumours without a somatic CTNNB1 variant, and says children with desmoplastic tumours showing extensive nodularity should be evaluated for signs of Gorlin syndrome.

Follow-up then runs for decades, and PDQ is specific: endocrinology evaluation once a year, neuropsychological testing every one to two years. Hearing is watched too, with similar rates of grade 3 and grade 4 ototoxicity reported for proton and photon therapy, pointing at contributors such as cisplatin.

How Healz holds the operative note, the pathology and the molecular report as one answer

The group decides the treatment, so the operative note, the pathology and the molecular report have to become one answer rather than three arrivals. Healz keeps everything in one place, one chat, not ten apps.

Healz is equipped with Frontier AI, so the case gets worked whole: the residual measurement, the spinal fluid cytology date and the group in one reading. An ai mri analysis of the staging report means little until it sits next to what the operation actually left.

Healz is equipped with root-cause technology, so it does not stop at the first label. It asks what a rushed appointment skips and cross-checks the case against 1M+ rare cases, which is how a report that says medulloblastoma and nothing else gets treated as incomplete instead of final, and how a predisposition syndrome stays on the list rather than surfacing years later.

Healz's memory pulls the medical facts out of every upload, dates them, keeps abnormal values up front and connects them across months. The morning vomiting logged in March sits beside the resection note from June and the audiology result the following spring, so a hearing change reads as a trend. That is also what a cancer ai is for when a family wants a second opinion on a plan: the whole case travels, not one page of it. You can bring a board-certified doctor into the same chat for a second opinion.

Frequently asked questions

Why does my child vomit in the morning and then feel better?

Raised pressure inside the skull typically produces headache on waking and vomiting, per the NCI PDQ health professional summary, and a 2013 review in Advances in Clinical Neuroscience and Rehabilitation notes that the hyperventilation that goes with vomiting often transiently improves the headache. The relief is real and it is not reassuring. A pattern repeating over weeks, especially alongside unsteadiness, is what prompts imaging.

Why does a medulloblastoma MRI include the whole spine?

Because the tumour spreads through cerebrospinal fluid, which circulates around the spinal cord as well as the brain. PDQ states that MRI of the entire brain and spine is indicated, preferably before surgery to avoid postoperative artefacts, especially blood.

What does the molecular group on a medulloblastoma report mean?

It names which biological disease the tumour is. The 2021 WHO classification, summarised by Louis and colleagues in Neuro-Oncology, defines WNT-activated, SHH-activated split by TP53 status, and non-WNT/non-SHH, which combines what people still call group 3 and group 4. PDQ reports the groups differ in age, frequency and outcome.

Why is radiation delayed or avoided in very young children?

Because of what it costs a developing brain. PDQ states that debilitating effects on neurocognitive development, growth and endocrine function have been frequently observed, especially in younger children, and that efforts are made to omit or delay radiation therapy. For children 3 years and under the described approach is surgery followed by chemotherapy.

A stomach bug, a migraine and a scan were three separate answers to one child, and the answer only appeared when somebody read them together.

Written by Healz Team · Filed under Health Insights

Your health deserves more than guesswork

Get a real investigation, not a symptom list. Root causes found, history remembered, dots connected.

Not a medical provider. Healz.ai is an educational service. Always discuss every decision with your doctor. AI can make mistakes.

© 2026 HealzAI Inc1111B S Governors Ave #92123, Dover, DE 19904, USAMade with for better health